Abstract: N-n-butyl haloperidol iodide (F 2 ), a novel compound, has shown palliative effects in myocardial ischemia/reperfusion (I/R) injury. In this study, we investigated the effects of F 2 on the extracellular signal-regulated kinase kinase (MEK)/extracellular signal-regulated kinase (ERK)/Na 
Introduction
Reperfusion of an ischemic myocardium leads to heart dysfunction and cardiomyocyte injury. Such myocardial ischemia/reperfusion (I/R) injury is characterized by impaired blood flow, metabolic dysfunction, contractile dysfunction, dysrhythmias, cellular necrosis, and apoptosis.
1 I/R injury is a complex process involving numerous mechanisms, including cytosolic and mitochondrial Ca 2+ overload, release of reactive oxygen species (ROS), acute inflammatory response, and shift in substrate use. 2 ROS, produced as by-products of oxidative metabolism, are easily managed under normal conditions by reactive oxygen scavengers. 3, 4 Several forms of ROS are generated during I/R, including superoxide (O 2 submit your manuscript | www.dovepress.com
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huang et al ROS upon reperfusion may contribute to Ca 2+ overload in cardiomyocytes. 7, 8 Rothstein et al 9 and Sabri et al 10 found that low doses of H 2 O 2 (50 µM, similar to those generated during I/R) cause Ca 2+ overload in cultured neonatal rat ventricular myocytes, which is associated with activation of the Na + /H + exchanger (NHE) in part through extracellular signal-regulated kinase (ERK)-1/2-mediated phosphorylation of NHE-1, the only NHE isoform in the myocardium. A link between H 2 O 2 and diastolic Ca 2+ overload in neonatal rat ventricular myocytes was proposed. Exposure to H 2 O 2 results in the alteration of signaling proteins involved in the mitogen-activated proteinkinase (MAPK) pathway, ultimately leading to extracellular signal-regulated kinase kinase (MEK) activation, which then phosphorylates and activates ERK1/2. Activated ERK1/2 subsequently phosphorylates the COOH tail of NHE-1, increasing its exchanger activity to elevate intracellular Na + concentrations. The resulting rise in intracellular Na + decreases the activity of the Na + /Ca 2+ exchanger (NCX), leading to an increase in diastolic Ca 2+ levels. 9 Therefore, pharmacological approaches to decrease MAPK, NHE-1, and/or NCX activity may ameliorate the alterations in Ca 2+ homeostasis that contribute to myocardial tissue injury following I/R. N-n-butyl haloperidol iodide (F 2 ), a novel quaternary ammonium salt derivative of haloperidol synthesized in our laboratory, can maintain the effects of coronary artery relaxation without adverse extrapyramidal reactions. 11 Our previous studies show that F 2 can attenuate myocardial I/R injury, as evidenced by amelioration of hemodynamics and myocardial enzyme activity, reduction in myocardial infarction size, prevention of ventricular arrhythmias, and decreases in myocardial inflammation. [11] [12] [13] [14] The cardioprotective mechanism of F 2 was thought to be associated with calcium-homeostasis maintenance against intracellular Ca 2+ overload by inhibiting cardiocyte L-type Ca 2+ channels. 12, 13 However, intracellular Ca 2+ overload during I/R results primarily from the functional coupling of NHE and NCX. Ischemic hearts develop intracellular acidosis, which activates NHE to extrude H + in exchange for an influx of Na + . Upon reperfusion, loss of extracellular H + causes further extrusion of H + in exchange for Na + . The subsequent elevation in intracellular Na + promotes an increase Ca 2+ influx into the cytosol via the reverse mode of NCX, resulting in Ca 2+ overload. 15 It is suggested that the mechanism of F 2 antagonizing myocardial I/R injury might not be only related to suppression of the L-type Ca 2+ channel. In this study, we used rat ventricular myocytes to investigate the effects of F 2 on the MEK/ERK/NHE/NCX signal-transduction pathway involved in H 2 O 2 -induced Ca 2+ overload in order to probe the underlying molecular mechanism by which F 2 maintains intracellular calcium homeostasis and antagonizes myocardial I/R injury. 16 The protocol was approved by the Medical Animal Care and Welfare Committee of Shantou University Medical College (permit SUMC2010-093). All surgery was performed under sodium pentobarbital anesthesia, and all efforts were made to minimize suffering. Single ventricular myocytes were isolated by an enzymatic dissociation method described previously. 17, 18 Single ventricular myocytes were harvested after filtration through a nylon mesh (pore size 200 mm). For recording I NCX , the extracellular solution contained ouabain, nifedipine, Cs + , and ryanodine to block Na + / K + pump current, I Ca , I K , and Ca 2+ release channels of the sarcoplasmic reticulum, respectively. I NCX was induced by ramp-voltage pulses from a holding potential of −60 mV to +60 mV, and then hyperpolarizing to −150 mV before ramping back to the holding potential at a rate of 600 mV/second. The descending limb (from +60 to −150 mV) was plotted as the current-voltage (I-V) relationship without capacitance compensation. 20 I NCX was measured as the N i 2+ -sensitive current that could be selectively inhibited by 5 mM NiCl 2 .
Materials and methods Materials
I ncX recording
Measurement of intracellular ph and nhe activity
Intracellular pH (pH i ) was measured by monitoring the fluorescence of the pH-sensitive dye BCECF. 9, 10 Myocytes placed in a petri dish were loaded with BCECF by incubation for 15 minutes in the dark at room temperature with the acetoxymethyl ester form (BCECF-AM, 2 µM) in modified Krebs solution (135 mM NaCl, 5.9 mM KCl, 1.5 mM CaCl 2 , 1.2 mM MgCl 2 , 11.5 mM glucose, 11.6 mM HEPES, pH 7.4) supplemented with 0.1% bovine serum albumin and 0.02% Pluronic F127. The cells were then washed three times and incubated for an additional 45 minutes in fresh Krebs solution in the presence or absence of the MEK inhibitor U0126 (5 µM). BCECF fluorescence was recorded using confocal microscopy (FluoView FV1000; Olympus, Tokyo, Japan). A ratio of fluorescence emitted at 515 nm from excitation at 490 nm to that at 440 nm was converted to intracellular pH i using the nigericin high-K + protocol of Thomas et al. 21 NHE activity was measured by monitoring the recovery rate from rapid acidification using the NH 4 Cl prepulse technique. 21, 22 After determination of basal pH i , cells were exposed to Krebs solution containing 25 mM NH 4 Cl for 5 minutes to cause rapid alkalinization as NH 3 diffused into the cells and titrated intracellular H + . Then, perfusion with Na + -free Krebs solution (Na + isosmotically replaced with N-methylglucamine) removed NH 4 + from the external medium to cause a rapid decrease in pH i . There was no recovery from this acid load in the absence of Na + . pH i recovered when the perfusate was switched to an Na + -containing Krebs solution. This Na + -dependent recovery was operationally defined as NHE activity. To quantify the rate of pH i recovery, the slope of a straight line fitted to the initial 60 seconds after the onset of recovery was measured. 10 
Western blotting
Total protein extracts were prepared from cells using cell-lysis buffer containing a protease-inhibitor cocktail (aprotinin, leupeptin, pepstatin A, and phenylmethylsulfonyl fluoride). The protein concentration was determined by a Bradford protein-assay kit (Bio-Rad Laboratories Inc., Hercules, CA, USA). Equal amounts of total protein (40 µg) were subjected to sodium dodecyl sulfate polyacrylamide gel electrophoresis (10%), followed by electrophoretic transfer to nitrocellulose membranes (GE Healthcare UK Ltd., Little Chalfont, UK). The blots were incubated with primary antibody (rabbit antirat) at 4°C overnight, followed by secondary antibody (horseradish peroxidase-conjugate goat antirabbit IgG) for 2 hours at room temperature. The bound antibodies were detected by the use of a SuperSignal Western blotting kit (Thermo Fisher Scientific ). Densitometric analysis of protein bands was performed with Quantity One ® software (version 4.5.2; Bio-Rad Laboratories Inc.,).
statistical analysis
All values are presented as means ± standard error of the mean. Statistical analysis was carried out using paired Students's t-tests or one-way analysis of variance followed by the Student-Newman-Keuls test, with P,0.05 considered statistically significant. stoichiometry was calculated to be −65 mV at room temperature according to the equation E Na/Ca =3E Na − 2E Ca . 23, 24 Figure 1A illustrates the I-V relation of control myocytes (a), and myocytes exposed to 
Results
U0126 and DMa inhibit h 2 O 2 -induced I ncX increases
To confirm the involvement of the MAPK pathway and the NHE in H 2 O 2 -induced NCX activation, we tested the effects of U0126, a highly selective inhibitor of MEK, and DMA, an NHE inhibitor, on the H 2 O 2 -induced increase in I NCX . We initially determined the minimal effective concentrations that completely blocked H 2 O 2 -induced MEK activation and NHE-1 activity, and used those concentrations to examine the roles of MEK and NHE in F 2 -mediated inhibition of H 2 O 2 -mediated induction of I NCX activity. Results showed that perfusion of 5 µM U0126 for 10 minutes, which alone did not affect I NCX , 25 significantly inhibited the H 2 O 2 -induced increase in I NCX at 60 mV by 81.13%±3.63% and at −150 mV by 93.64%±4.52% (n=5) (Figure 2A and B) . In contrast, perfusion of 20 µM DMA for 10 minutes only inhibited the H 2 O 2 -induced increase by 39.98%±3.00% at 60 mV, and by 32.42%±1.78% at −150 mV (n=5) (Figure 2C and D) . This result indicates that the H 2 O 2 -induced increase in I NCX was primarily mediated by the MEK/MAPK pathway, and partially through activation of NHE-1.
F 2 inhibits h 2 O 2 -induced MeK/erK activation and egF-induced I ncX increases
To investigate whether F 2 modulates MEK activity, we examined the effect of F 2 on H 2 O 2 -induced and EGF-induced MEK/ERK activation. As shown in Figure 3A , H 2 O 2 (100 µM) and EGF (50 ng/mL) led to a significant increase in the level of phosphorylated MEK and ERK, and 1 µM F 2 inhibited both H 2 O 2 -induced and EGF-induced MEK and ERK activation. We then observed the effect of F 2 on the I NCX increase induced by EGF. I NCX was increased by EGF, and treatment with 1 µM F 2 resulted in a significant reduction in EGF-induced I NCX rise at 60 mV by 72.88%±5.76% and at −150mV by 71.14%±3.19% (n=8) ( Figure 3B ).
F 2 inhibits h 2 O 2 -induced and ang iiinduced nhe activity
To investigate the effects of F 2 on NHE activity, we examined its effects on H 2 O 2 -induced and Ang II-induced, Na + -dependent recovery from acid load in rat ventricular myocytes. The mean resting pH of ventricular myocytes in bicarbonate-free Krebs solution at room temperature was 7.48±0.13 (n=10). The addition and removal of NH 4 Cl from the external medium caused a rapid rise and decrease in pH i . Cells were unable to recover from this acid load in Na + -free medium. Reintroduction of Na + led to a rapid recovery of pH i that approached resting values ( Figure 4A ). This Na + -dependent recovery was completely blocked by DMA (25 µM) ( Figure 4B ). Exposure to Figure 4E ). Perfusion with 1 µM F 2 completely blocked both Na + -dependent recovery in the presence of H 2 O 2 ( Figure 4F ) and NHE activity in the presence of 1 nM Ang II ( Figure 4G ). These results suggest that F 2 exerted its cardioprotective effects by blocking NHE activity.
F 2 inhibits ang ii-induced I ncX increases
Ang II at a low concentration stimulates NHE-1 activity to elevate intracellular Na + levels, 26, 27 which reverses NCX activity and leads to I NCX increases. We observed that 1 nM Ang II increased outward I NCX at 60 mV by 26.92%±4.40% and inward I NCX at −150 mV by 14.26%±2.95% (n=5), consistent with a prior report. 28 Addition of 1 µM F 2 resulted in a significant reduction in the Ang II-induced I NCX rise at 60 mV by 62.27%±3.42% and at −150 mV by 46.19%±3.36% (n=5) (Figure 5 ), consistent with a role for F 2 in blocking NHE activation.
effects of F 2 on the protein expression of nhe and ncX
Exchanger activity is regulated by changes in protein expression and by phosphorylation of existing exchangers or a closely associated modulatory protein. [29] [30] [31] [32] [33] Therefore, we examined the effects of F 2 on the protein expression of NHE and NCX. The results showed that the total protein expression of NHE and NCX did not change after myocytes were treated 
Discussion
The present study describes the effects of 38 which are activated during ischemia, and to a greater extent on reperfusion. 39, 40 Activated ERK1/2 leads to phosphorylation and activation of NHE-1, 9, 41 and this may contribute to a feed-forward activation loop (Ca 2+ → ROS → ERK → more Na + → more Ca 2+ ), enhancing Ca 2+ overload in I/R injury. 37 The ability to disrupt this vicious cycle will exert beneficial effects on recovery from I/R injury. In this study, we demonstrated that F 2 can inhibit H 2 O 2 -induced increase in NCX activity through inhibiting both MEK/ERK activation and NHE activity, blocking intracellular Ca 2+ overload to protect against myocardial I/R injury.
Our results show that acute exposure of cardiac myocytes to 100 µM H 2 O 2 causes the I NCX to increase, along with a rapid activation of MEK and an increase in NHE activity. The H 2 O 2 -induced I NCX increase was blocked almost completely by the MEK inhibitor U0126, but only partly by the NHE inhibitor DMA (Figure 2 ), indicating the I NCX increase was primarily mediated by the MEK MAPK pathway and partially through activation of NHE, consistent with prior reports. 9, 25 Furthermore, the H 2 O 2 -induced increase in NHE activity was abolished by pretreatment with the MEK inhibitor U0126 ( Figure 4E ), suggesting that MAPKs act upstream of NHE in H 2 O 2 -induced I NCX increase. The present study shows that F 2 blocks MEK activation-induced by not only H 2 O 2 but also EGF ( Figure 3A) , suggesting that F 2 directly inhibits MEK activation.
Dyck et al found an increase in steady-state levels of NHE-1 messenger ribonucleic acid in chronic ischemia in rat myocardium, suggesting that increased activity is due to an increase in protein expression. 31 However, in our experiments, acute exposure to H 2 O 2 caused a rapid activation of NHE and NCX activity in the absence of changes in total NHE and NCX. The most likely explanation is that the exposure to H 2 O 2 in our experiment was too short for changes in protein expression, indicating that posttranslational modification rather than gene expression played the major role in the rapid time course for regulation of exchanger activity. Unfortunately, we could not detect phosphorylation of NHE-1 and NCX due to the absence of antibodies for phospho-NHE-1 and phospho-NCX, which was a limitation of this study.
NHE 12, 14, 18, 44 We now show an additional mechanism for F 2 in the regulation of calcium homeostasis, demonstrating that F 2 inhibits both MEK activation and NHE activity to diminish H 2 O 2 -induced I NCX increase, but we do not rule out inhibition by F 2 on NCX activity. Figure 7 illustrates the possible signaling pathways from H 2 O 2 to NCX and the target of F 2 action.
In conclusion, we demonstrate an additional mechanism by which F 2 can alleviate intracellular Ca 2+ overload, and thus protect against myocardial I/R injury. F 2 , a novel quaternary ammonium salt derivative of haloperidol with a different chemical structure from classical Ca 2+ -channel antagonists, seems like an undesirable drug due to its broad, nonspecific 
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